Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to assess the safety and tolerability of
aripiprazole in patients with psychosis associated with Parkinson's disease.
Phase:
Phase 4
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.